Product Details
Place of Origin: China
Brand Name: Quickoolchem
Payment & Shipping Terms
Minimum Order Quantity: 50 grams
Price: Negotiable
Packaging Details: 1kg/Bag; 25kg/Carton
Delivery Time: 2-3 days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 10 MT/Month
Purity: |
≥99% |
Molecular Formula: |
C13H19N3O7 |
Density: |
1.46 G/cm3 |
Cas Number: |
2349386-89-4 |
Flash Point: |
316.5°C |
Storage: |
Store At -20°C |
Refractive Index: |
1.617 |
Appearance: |
White To Off-white Powder |
Origin: |
China |
Package: |
1kg/bag, 25kg/drum |
Purity: |
≥99% |
Molecular Formula: |
C13H19N3O7 |
Density: |
1.46 G/cm3 |
Cas Number: |
2349386-89-4 |
Flash Point: |
316.5°C |
Storage: |
Store At -20°C |
Refractive Index: |
1.617 |
Appearance: |
White To Off-white Powder |
Origin: |
China |
Package: |
1kg/bag, 25kg/drum |
Feline Infectious Peritonitis (FIP) is a viral disease caused by certain strains of feline coronavirus (FCoV). It's a severe and often fatal condition in cats.
Molnupiravir has shown broad-spectrum antiviral activity against various RNA viruses, including coronaviruses. Since FIP is caused by a coronavirus, there is a theoretical basis for investigating whether Molnupiravir could inhibit the replication of the virus responsible for FIP.
There are several factors to consider when exploring the use of Molnupiravir for FIP treatment. These include the severity of the disease, the stage at which the cat is diagnosed, potential side effects, and the cost-effectiveness of treatment. Additionally, FIP can manifest in various forms, including wet (effusive) and dry (non-effusive) forms, which may influence treatment strategies.
| Solubility: | Soluble In DMSO And Methanol |
| Flash Point: | 316.5°C |
| Boiling Point: | ~600.3°C At 760 MmHg |
| Density: | 1.46 G/cm3 |
| Appearance: | White To Off-white Powder |
| Storage: | Store At -20°C |
| Purity: | ≥99% |
| Refractive Index: | 1.617 |
| Synonyms: | EIDD-2801; MK-4482; Molnupiravir Prodrug |
| Cas Number: | 2349386-89-4 |
This antiviral medication is suitable for various application occasions and scenarios. It can be used in hospitals, clinics, research institutions, and pharmaceutical companies. Molnupiravir EIDD-2801(New) can be used in the treatment of COVID-19 patients with mild and moderate symptoms. It can also be used for people who have been in contact with COVID-19 patients as a preventive measure.
1~25kgs packaging: Aluminium bag inside, Carton box outside.
25kgs packaging: Plastic bag inside, Fiber drum outside
